Ensysce Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of solutions for severe pain relief while reducing the fear of and the potential for misuse and overdose. The firm's Trypsin Activated Abuse Protection and Multi-Pill Abuse Resistance platforms are in the process of developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. The company was founded in April 2003 and is headquartered in La Jolla, CA.
コメント:
Nice Setup
コメント:
I have not taken an entry into this yet however, ENSC 1M Post Split $1.15-$1.34 Entry is a good place.
トレード終了: 利益確定目標に到達